Open access · CC-BY
via OpenAlex
Targeting the Nrf2/TGF‐β1/Smad Signaling Pathway: A Novel Strategy for Urolithin A to Alleviate Renal Fibrosis
Xue Wu, Jiating Li, Yonghui Dong, Jia Li, Ji Bian, Chao Liu, Hongbo Zhang, Lin Han, Min Wang
Food Frontiers · 2025 · ▲ 1 citations
Abstract
ABSTRACT The global prevalence and mortality rates associated with chronic kidney disease (CKD) have been on a continuous rise over recent decades. Renal fibrosis (RF) serves as a critical factor in the progression of CKD to end‐stage renal disease. This study aims to investigate the effect of urolithin A (UroA) on folic acid‐induced RF and to elucidate its underlying mechanisms. By establishing a mouse model of renal fibrosis and an in vitro model of epithelial‐mesenchymal transition (EMT) using human renal proximal tubule epithelial cells (HK‐2), the findings indicate that UroA has the potential to enhance renal function, mitigate renal pathological damage, and inhibit the expression of extracellular matrix components as well as the EMT process in mice with RF. Mechanistically, UroA promotes the phosphorylation of Nrf2 and its subsequent nuclear translocation, thereby activating the Nrf2/HO‐1 signaling pathway to counteract oxidative stress. Furthermore, UroA modulates the Smad signaling pathway by upregulating Nrf2, which in turn reduces the EMT of HK‐2 cells induced by TGF‐β1. These results suggest that orally administered UroA represents a promising therapeutic strategy capable of ameliorating cellular oxidative damage, obstructing EMT, reducing renal injury, and delaying the decline in renal function by regulating the Nrf2/TGF‐β1/Smad axis. This distinctive mechanism offers valuable insights into targeted therapeutic strategies for RF and the potential application of UroA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/fft2.70136
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Wu, X., Li, J., Dong, Y., Li, J., Bian, J., Liu, C., Zhang, H., Han, L., & Wang, M. (2025). Targeting the Nrf2/TGF‐β1/Smad Signaling Pathway: A Novel Strategy for Urolithin A to Alleviate Renal Fibrosis. <em>Food Frontiers</em>. https://doi.org/10.1002/fft2.70136
Vancouver
Wu X, Li J, Dong Y, Li J, Bian J, Liu C, et al. Targeting the Nrf2/TGF‐β1/Smad Signaling Pathway: A Novel Strategy for Urolithin A to Alleviate Renal Fibrosis. Food Frontiers. 2025. doi:10.1002/fft2.70136.
BibTeX
@article{xue2025Target,
title = {Targeting the Nrf2/TGF‐β1/Smad Signaling Pathway: A Novel Strategy for Urolithin A to Alleviate Renal Fibrosis},
author = {Xue Wu and Jiating Li and Yonghui Dong and Jia Li and Ji Bian and Chao Liu and Hongbo Zhang and Lin Han and Min Wang},
journal = {Food Frontiers},
year = {2025},
doi = {10.1002/fft2.70136},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomaterials 2024
Open access · CC-BY
Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPARα signaling in renal tubular epithelial cells
The international journal of biochemistry & cell biology 2026
Citation only
MicroRNAs in renal fibrosis: Unraveling mechanisms and therapeutic potential.
In Vitro Cellular & Developmental Biology - Animal 2023
Open access · CC-BY
Ecliptasaponin A attenuates renal fibrosis by regulating the extracellular matrix of renal tubular cells
Nephrology Dialysis Transplantation 2025
Open access · OA
#2529 Nanoparticle-mediated Klotho gene therapy prevents kidney disease progression via PPARα pathway
Research Square 2026
Preprint · CC-BY
Urolithin A preserves renal perfusion and function and attenuates inflammasome-associated signaling in a translational porcine model of sepsis-induced acute kidney injury
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY